Weighted Average Number of Shares Outstanding, Basic of Vor Biopharma Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Vor Biopharma Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2025.
  • Vor Biopharma Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 6.68M shares, a 95.2% increase year-over-year.
  • Vor Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 68.7M shares, a 2.25% increase from 2023.
  • Vor Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 67.2M shares, a 69.9% increase from 2022.
  • Vor Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 39.6M shares, a 18.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Vor Biopharma Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 6.68M +3.26M +95.2% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 125M +57M +83.4% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 125M +56.8M +83.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 68.7M +1.51M +2.25% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-20
Q3 2024 3.42M -64.2M -94.9% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 68.3M +1.27M +1.89% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 68M +1.77M +2.66% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q4 2023 67.2M +27.6M +69.9% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-20
Q3 2023 67.6M +29.6M +77.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 67M +29.6M +79.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 66.3M +29M +77.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 39.6M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 38M +1.07M +2.91% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 37.4M +594K +1.61% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 37.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 36.9M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 36.8M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11

Vor Biopharma Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 68.7M +1.51M +2.25% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 67.2M +27.6M +69.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 39.6M +6.12M +18.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 33.4M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.